Indivior PLC Ordinary Shares (INDV)

Official site

HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

$33.62

-0.54 (-1.58%)

Market Cap: $4.03B

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

70%(21/30)

Avg Surprise

-7.59%

Streak

7 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$1.12

Range$1.09 - $1.15

2 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$0.99+13.0%

60d ago$0.99+13.0%

30d ago$0.97+15.3%

7d ago$0.98+14.1%

Current$1.12

Revenue Consensus

$329M

Range$327M - $332M

2 analysts

Period ending Dec 31, 2026

EPS Consensus$1.71

Range$1.66 - $1.77

3 analysts

Revenue Consensus

$422M

Range$408M - $432M

3 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$1.71	$1.66 - $1.77	-	-	3	-	-
Sep 30, 2026Sep 26EST	-	$1.12	$1.09 - $1.15	-	-	2	2 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 3, 2026Reported Aug 3	$1.15	$0.97	$0.87 - $0.97	+18.56%	Beat	4	2 0 30d	+125.5%
Mar 31, 2026Mar 26 Reported Apr 30, 2026Reported Apr 30	$0.96	$0.66	$0.61 - $0.71	+45.45%	Beat	5	2 2 30d	+134.1%
Dec 31, 2025Dec 25 Reported Feb 26, 2026Reported Feb 26	$0.82	$0.65	$0.53 - $0.73	+26.15%	Beat	5	0 1 30d	+157.1%
Sep 30, 2025Sep 25 Reported Oct 30, 2025Reported Oct 30	$0.72	$0.41	$0.33 - $0.51	+75.61%	Beat	6	3 0 30d	+2300.0%
Jun 30, 2025Jun 25 Reported Jul 31, 2025Reported Jul 31	$0.51	$0.25	$0.22 - $0.27	+104.00%	Beat	3	1 0 30d	+15.9%
Mar 31, 2025Mar 25 Reported Apr 24, 2025Reported Apr 24	$0.41	$0.23	$0.20 - $0.27	+78.26%	Beat	3	0 2 30d	+10.8%
Dec 31, 2024Dec 24 Reported Feb 20, 2025Reported Feb 20	$0.32	$0.26	$0.14 - $0.32	+22.65%	Beat	3	0 1 30d	-25.8%
Sep 30, 2024Sep 24 Reported Oct 24, 2024Reported Oct 24	$0.03	N/A	-	-90.32%	Miss	2	1 0 30d	-91.2%
Jun 30, 2024Jun 24 Reported Jul 25, 2024Reported Jul 25	$0.44	$0.40	$-0.78 - $0.44	+10.00%	Beat	2	2 1 30d	+12.8%
Mar 31, 2024Mar 24 Reported Apr 25, 2024Reported Apr 25	$0.37	$0.42	$0.38 - $0.45	-11.90%	Miss	2	No revisions (30d)	-7.5%
Dec 31, 2023Dec 23 Reported Feb 22, 2024Reported Feb 22	$0.43	$0.28	$0.28 - $0.28	+53.57%	Beat	1	No revisions (30d)	+132.1%
Sep 30, 2023Sep 23 Reported Nov 9, 2023Reported Nov 9	$0.34	$0.30	$0.30 - $0.30	+13.33%	Beat	1	No revisions (30d)	+21.4%
Jun 30, 2023Jun 23 Reported Jul 27, 2023Reported Jul 27	$0.39	$0.22	-	+77.27%	Beat	-	-	+13.5%
Mar 31, 2023Mar 23 Reported Apr 27, 2023Reported Apr 27	$0.40	$0.40	-	+0.00%	Beat	-	-	+45.3%
Dec 31, 2022Dec 22 Reported Feb 16, 2023Reported Feb 16	$-1.34	$0.27	-	-596.59%	Miss	-	-	-638.3%
Sep 30, 2022Sep 22 Reported Oct 27, 2022Reported Oct 27	$0.28	$0.29	-	-3.45%	Miss	-	-	+86.7%
Jun 30, 2022Jun 22 Reported Jul 28, 2022Reported Jul 28	$0.34	$0.30	-	+14.53%	Beat	-	-	-14.1%
Mar 31, 2022Mar 22 Reported Apr 28, 2022Reported Apr 28	$0.28	$0.30	-	-8.27%	Miss	-	-	-46.2%
Dec 31, 2021Dec 21 Reported Feb 16, 2022Reported Feb 16	$0.25	$0.15	-	+66.07%	Beat	-	-	+381.2%
Sep 30, 2021Sep 21 Reported Oct 28, 2021Reported Oct 28	$0.15	$0.15	-	+0.00%	Beat	-	-	+200.0%
Jun 30, 2021Jun 21 Reported Jul 29, 2021Reported Jul 29	$0.40	$0.30	-	+33.33%	Beat	-	-	+300.0%
Mar 31, 2021Mar 21 Reported Apr 29, 2021Reported Apr 29	$0.51	$0.25	-	+104.76%	Beat	-	-	+146.0%
Dec 31, 2020Dec 20 Reported Feb 18, 2021Reported Feb 18	$-0.09	$0.15	-	-159.07%	Miss	-	-	+76.5%
Sep 30, 2020Sep 20 Reported Oct 29, 2020Reported Oct 29	$0.05	$0.10	-	-50.00%	Miss	-	-	-83.3%
Jun 30, 2020Jun 20 Reported Jul 30, 2020Reported Jul 30	$0.10	$0.10	-	+0.00%	Beat	-	-	-80.0%
Mar 31, 2020Mar 20 Reported May 14, 2020Reported May 14	$-1.11	$-1.10	-	-1.22%	Miss	-	-	-355.2%
Dec 31, 2019Dec 19 Reported Feb 13, 2020Reported Feb 13	$-0.38	$-0.25	-	-50.52%	Miss	-	-	-328.5%
Sep 30, 2019Sep 19 Reported Oct 31, 2019Reported Oct 31	$0.30	$0.30	-	+0.00%	Beat	-	-	-50.9%
Jun 30, 2019Jun 19 Reported Jul 31, 2019Reported Jul 31	$0.50	$0.50	-	+0.00%	Beat	-	-	+11.1%
Mar 31, 2019Mar 19 Reported May 2, 2019Reported May 2	$0.44	N/A	-	N/A	Beat	-	-	-29.8%
Dec 31, 2018Dec 18 Reported Feb 14, 2019Reported Feb 14	$0.16	N/A	-	N/A	Beat	-	-	+116.4%
Sep 30, 2018Sep 18 Reported Nov 1, 2018Reported Nov 1	$0.61	N/A	-	N/A	Beat	-	-	+76.3%
Jun 30, 2018Jun 18 Reported Jul 25, 2018Reported Jul 25	$0.45	N/A	-	N/A	Beat	-	-	-11.1%
Mar 31, 2018Mar 18 Reported May 2, 2018Reported May 2	$0.62	N/A	-	N/A	Beat	-	-	+16.2%
Dec 31, 2017Dec 17 Reported Feb 15, 2018Reported Feb 15	$-1.00	N/A	-	N/A	Beat	-	-	-387.1%
Sep 30, 2017Sep 17 Reported Nov 2, 2017Reported Nov 2	$0.35	N/A	-	N/A	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Jul 27, 2017Reported Jul 27	$0.51	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 3, 2017Reported May 3	$0.53	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Feb 22, 2017Reported Feb 22	$0.35	$0.35	-	+0.00%	Beat	-	-	-

Dividends

Dividend Metrics

Forward Yield0.00%

Forward Annual Dividend$0.00

Payout Ratio0.00%

Pay MonthsNov

Key Metrics

Valuation
P/E Ratio	9.21	EV/EBITDA	9.72x
Price/FCF	-36.04x	FCF Yield	-2.77%
Profitability
Profit Margin	26.80%	Operating Margin	46.90%
ROE	12.20%	ROIC	136.31%
Financial Health
Debt/Equity	-2.34x	Interest Coverage	9.36x
Current Ratio	0.84x	Quick Ratio	0.66x
Trading Statistics
Beta	1.18	Avg Volume	2.41M
52-Week High	$42.81	52-Week Low	$23.72

Technical Indicators Dashboard

Moving Averages

SMA 10$35.43

SMA 20$35.66

SMA 50$36.10

SMA 200$35.71

EMA 10$35.15

EMA 20$35.44

EMA 50$36.12

EMA 200$34.53

MACD

Line: -0.34Signal: -0.17Hist: -0.16

ADX

ADX: 23.2+DI: 9.8-DI: 24.5

Aroon & PSAR

Aroon Up52.0

Aroon Down100.0

PSAR$36.30

Bollinger Bands

Upper Band$37.16

Lower Band$34.17

%B Position840%(Upper)

Band Width-0.18

RSI (14-Day)

Neutral

34.6

Momentum Oscillators

Stoch %K11.2

Stoch %D27.3

Williams %R-97.7

ROC (10d)-5.0%

Momentum-1.76

CCI (20d)-280.4

MFI (14d)61.6

Volatility Measures

ATR (14d)$1.11(3.3%)

StdDev (20d)0.75

Hist Vol26.2%(Moderate)

Volume Flow

VWAP$34.01

OBV96.0M

AD Line4.6M

CMF (20d)-0.025

Volume Metrics

Avg Vol (20d)2.4M

Vol Ratio0.7x

VWMA (20d)$35.65

Pivot Points

R3$37.95

R2$37.13

R1$35.64

Pivot Point$34.82

S1$33.33

S2$32.51

S3$31.02

Advanced Oscillators

TSI-10.30

Ultimate Osc38.3

KST-4.92

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$343.00M	$317.00M	$357.00M	$314.00M	$302.00M	$266.00M	$298.00M	$307.00M	$299.00M	$284.00M	$293.00M	$271.00M
Cost of Revenue	$50.00M	$40.00M	$67.00M	$83.00M	$52.00M	$44.00M	$48.00M	$66.00M	$79.00M	$38.00M	$51.00M	$46.00M
Gross Profit	$294.00M	$277.00M	$293.00M	$230.00M	$250.00M	$221.00M	$250.00M	$241.00M	$220.00M	$246.00M	$242.00M	$225.00M

Operating Expenses	$134.00M	$140.00M	$210.00M	$187.00M	$179.00M	$155.00M	$205.00M	$205.00M	$338.00M	$171.00M	$181.00M	$408.00M
R&D	$12.00M	$16.00M	$21.00M	$33.00M	$21.00M	$22.00M	$31.00M	$23.00M	$26.00M	$28.00M	$29.00M	$18.00M
SG&A	$122.00M	$124.00M	$189.00M	$155.00M	$158.00M	$133.00M	$175.00M	$142.00M	$152.00M	$143.00M	$89.00M	$390.00M
Operating Income	$160.00M	$137.00M	$81.00M	$43.00M	$72.00M	$66.00M	$46.00M	$35.00M	$-118,000,000	$75.00M	$61.00M	$-183,000,000

Interest Income	$3.00M	$3.00M	$6.00M	$6.00M	$6.00M	$4.00M	$5.00M	$5.00M	$6.00M	$7.00M	$10.00M	$12.00M
Interest Expense	$2.00M	$25.00M	$6.00M	$12.00M	$15.00M	$12.00M	$12.00M	$11.00M	$9.00M	$9.00M	$9.00M	$10.00M
Income Before Tax	$160.00M	$115.00M	$81.00M	$37.00M	$62.00M	$59.00M	$38.00M	$30.00M	$-121,000,000	$73.00M	$62.00M	$-181,000,000
Income Tax Expense	$38.00M	$26.00M	$-21,000,000	$-5,000,000	$44.00M	$11.00M	$17.00M	$8.00M	$-23,000,000	$11.00M	$8.00M	$-46,000,000

Net Income	$122.00M	$89.00M	$103.00M	$42.00M	$18.00M	$47.00M	$21.00M	$22.00M	$-97,000,000	$61.00M	$54.00M	$-135,000,000

EBITDA	$164.00M	$141.00M	$86.00M	$48.00M	$77.00M	$71.00M	$55.00M	$43.00M	$-116,000,000	$80.00M	$79.00M	$-164,000,000
EBIT	$160.00M	$137.00M	$81.00M	$43.00M	$72.00M	$66.00M	$46.00M	$35.00M	$-118,000,000	$75.00M	$70.00M	$-171,000,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about INDV

Government Contracts

Gov Obligations (TTM)

$8.70M

Gov Obligations / Revenue

0.7%

Obligations YoY

-26.4%

Active Awards

New Awards (TTM)

Avg Remaining Term

85.7 mo

Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

News

Barclays cuts target for Indivior stock to USD 43.00

Barclays has reduced its price target for Indivior stock from USD 46.00 to USD 43.00. The specialty pharmaceutical company is set to report its next results on October 29...

ad-hoc-news.de•Oct 15, 2026 7:39 PM ET10/15/26•Somewhat-Bearish

Indivior stock gains as Supernus merger and special dividend plan come into focus

Indivior stock has seen gains, closing at USD 34.77 on Nasdaq, driven by its planned all-stock merger with Supernus Pharmaceuticals and a USD 1 billion special dividend to shareholders. The company...

ad-hoc-news.de•Oct 10, 2026 2:13 AM ET10/10/26•Bullish

Indivior declares a special dividend per Indivior stock

Indivior has declared a special dividend of USD 8.13 per stock, payable on November 6, 2026, contingent on the completion of the proposed Supernus Pharmaceuticals merger. This announcement follows a strong second quarter...

AD HOC NEWS•Oct 7, 2026 1:28 AM ET10/7/26•Bullish

Indivior stock pre-market at EUR 32.10: plus 0.00 percent

Indivior stock remained unchanged pre-market at EUR 32.10, according to Lang & Schwarz. The company has declared a contingent special cash dividend of USD 8.13 per share...

AD HOC NEWS•Oct 6, 2026 4:37 AM ET10/6/26•Neutral

Indivior stock after-hours at EUR 31.90: plus 0.63 percent versus prior close

Indivior stock closed after-hours at EUR 31.90, marking a 0.63 percent increase from its prior close. The company announced a conditional special cash dividend of USD 8.13 per share...

AD HOC NEWS•Oct 5, 2026 4:26 PM ET10/5/26•Somewhat-Bullish

INDV Valuation and Fair Value

P/E: 9.2x
Forward P/E: 9.5x
EV/EBITDA: 9.7x
P/FCF: -36.0x
P/B: -19.3x

See GNG's fair value

INDV Profitability: Margins, ROIC and FCF

Gross margin: 82.2%
Operating margin: 46.9%
Net margin: 26.8%
ROIC: 136.3%
ROE: 12.2%
FCF margin: -8.3%
FCF yield: -2.8%

INDV Competitors

Company	Ticker
Adaptive Biotechnologies Corp	ADPT
Edgewise Therapeutics Inc	EWTX
Premier Inc	PINC
Catalyst Pharmaceuticals Inc	CPRX
Regencell Bioscience Holdings Ltd	RGC
Tango Therapeutics Inc	TNGX
ICU Medical Inc	ICUI
Envista Holdings Corp	NVST

Sector: Healthcare

INDV Analyst Ratings

Consensus: Buy
Analysts: 6
Strong Buy: 2
Buy: 4
Hold: 0
Sell: 0
Strong Sell: 0

INDV Bull Case vs Bear Case

Bull case

INDV earns a 136.3% return on invested capital.
INDV has a 26.8% net profit margin.
INDV beat EPS estimates in 87.5% of its last 8 reported quarters.

INDV Earnings: Beat Rate and Next Report

Beat rate: 7 of 8 quarters (87.5%)
Average surprise: 35.0%
EPS estimate (fiscal period ending Sep 30, 2026): $1.12
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 2 up, 0 down

INDV Dividend

Forward yield: 0.0%
Payout ratio: 0.0%
Pay months: Nov

Frequently Asked Questions About INDV

Does INDV pay dividends?

Indivior PLC Ordinary Shares (INDV) has a dividend payment track record. See the INDV dividend history page for its current payment status, TTM yield, and recorded payments.

What is INDV's P/E ratio?

Indivior PLC Ordinary Shares has a price-to-earnings (P/E) ratio of 9.21.

What is INDV's market cap?

Indivior PLC Ordinary Shares (INDV) has a market capitalization of $4.03B with a current stock price of $33.62.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In